ARTICLE | Clinical News
Rituxan rituximab: Phase III data
June 26, 2006 7:00 AM UTC
Data from the double blind, placebo-controlled, international Phase III REFLEX trial in 463 evaluable patients showed that Rituxan plus methotrexate (MTX) reduced joint erosion and joint space narrowi...